Drug firm Ipca Laboratories on Thursday reported a 35.44 percent rise in consolidated net profit to Rs 267.56 crore for the third quarter ended December 2020, on the back of robust sales in domestic and international markets. The company had posted a net profit of Rs197.54 crore for the same period of the previous fiscal, Ipca Labs said in a BSE filing.
Its consolidated total income stood at Rs1,425.21 crore for the quarter under consideration. It was Rs1,230.99 crore for in the year-ago period, it added. Indian formulations income was up 8 percent at Rs 523.16 crore for the quarter ended December this fiscal, and export income rose 21 percent to Rs 709.25 crore, the company said.
Shares of Ipca Laboratories were trading at Rs1,990per scrip on BSE, down 2.35 percent from its previous close.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
BJP's Hindi heartland dominance faces test in phase 3 polls
May 2, 2024 9:14 PM
Lok Sabha Election: Re-elections at a Ajmer booth after presiding officer misplaces register of voters
May 2, 2024 4:54 PM